Your browser doesn't support javascript.
loading
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
Vandekerkhove, Gillian; Lavoie, Jean-Michel; Annala, Matti; Murtha, Andrew J; Sundahl, Nora; Walz, Simon; Sano, Takeshi; Taavitsainen, Sinja; Ritch, Elie; Fazli, Ladan; Hurtado-Coll, Antonio; Wang, Gang; Nykter, Matti; Black, Peter C; Todenhöfer, Tilman; Ost, Piet; Gibb, Ewan A; Chi, Kim N; Eigl, Bernhard J; Wyatt, Alexander W.
Afiliación
  • Vandekerkhove G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Lavoie JM; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Annala M; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Murtha AJ; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Sundahl N; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Walz S; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
  • Sano T; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Taavitsainen S; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Ritch E; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Fazli L; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Hurtado-Coll A; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Wang G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Nykter M; Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC, Canada.
  • Black PC; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Todenhöfer T; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Ost P; Studienpraxis Urologie, Nuertingen, Germany.
  • Gibb EA; Medical School, Eberhard-Karls-University Tübingen, Tübingen, Germany.
  • Chi KN; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
  • Eigl BJ; Decipher Biosciences, Inc., Vancouver, BC, Canada.
  • Wyatt AW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Nat Commun ; 12(1): 184, 2021 01 08.
Article en En | MEDLINE | ID: mdl-33420073
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasma / Neoplasias de la Vejiga Urinaria / Genómica / ADN Tumoral Circulante Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasma / Neoplasias de la Vejiga Urinaria / Genómica / ADN Tumoral Circulante Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido